Quarterly ResultMay 5, 2026, 04:25 PM
Sotera Health Q1 Net Income $26.6M, EPS $0.09; Revenue $280M
AI Summary
Sotera Health reported a net income of $26.6 million for the first quarter of 2026, a significant turnaround from a net loss of $13.3 million in the prior year's quarter. Total net revenues increased to $280.0 million, up from $254.5 million year-over-year, with basic earnings per share reaching $0.09. The company also provided updates on ongoing ethylene oxide tort litigation in California and Georgia.
Key Highlights
- Q1 2026 Net Income was $26.6 million, a significant improvement from a $13.3 million net loss in Q1 2025.
- Total Net Revenues increased to $280.0 million in Q1 2026 from $254.5 million in Q1 2025.
- Basic Earnings Per Share was $0.09 in Q1 2026, up from a loss of $0.05 in Q1 2025.
- Sterigenics segment revenue grew to $186.1 million in Q1 2026 from $169.7 million in Q1 2025.
- Nordion segment revenue increased to $42.0 million in Q1 2026 from $32.6 million in Q1 2025.
- Nelson Labs segment revenue was $51.9 million in Q1 2026, slightly down from $52.3 million in Q1 2025.
- Net cash provided by operating activities decreased to $29.4 million in Q1 2026 from $55.5 million in Q1 2025.
- Illinois EO litigation settlement expense was $0 in Q1 2026, compared to $30.9 million in Q1 2025.
Price Impact
More from SHC